The impact of time to surgery on oncological outcomes in stage I-III dMMR colon cancer – A nationwide cohort study

Tobias Freyberg Justesen(Zealand University Hospital), Ismail Gögenür(University of Copenhagen), Maliha Mashkoor(Zealand University Hospital Køge), Andreas Weinberger Rosen(Zealand University Hospital), Johan Clausen(Zealand University Hospital Køge), Mikail Gögenur(Zealand University Hospital Køge)
European Journal of Surgical Oncology
March 24, 2023
10.1016/j.ejso.2023.03.223
Cited by 3

Related Papers

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
|British Journal of Cancer|2020|1.7k
Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study
|The Lancet Oncology|2014|477
The Safety of Melatonin in Humans
|Clinical Drug Investigation|2015|464
Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery
|JAMA Surgery|2023|434
Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation
|BMC Cancer|2019|362